Structure via PubChem · Public domain (PubChem)
pimecrolimus
Sign in to saveAlso known as ASM981, SDZ ASM 981, SDZ-ASM 981, 33-epi-chloro-33-desoxyascomycin
Pimecrolimus is an immunosuppressant drug of the calcineurin inhibitor class used in the treatment of atopic dermatitis (eczema).
In the Vinony graph
Within Vinony's link graph, pimecrolimus is referenced by 262 other articles, and connects out to immunosuppressive drug, lithium and United Kingdom.
It is catalogued under topics including Disulfiram-like drugs, Drugboxes which contain changes to verified fields and Drugboxes which contain changes to watched fields.
Its subject is documented across 20 Wikipedia language editions.
Key facts
- Drug.IUPAC_name
- (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-3-{(E)-2-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]-1-methylvinyl}-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosin-1,7,20,21(4H,23H)-tetrone
- Drug.image
- Pimecrolimus.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 200
- Drug.image2
- Pimecrolimus ball-and-stick.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Elidel
- Drug.pregnancy_AU
- B3
- Drug.pregnancy_US
- C
- Drug.legal_US
- Rx-only
- Drug.routes_of_administration
- topical
- Drug.class
- immunosuppressant
- Drug.bioavailability
- low systemic absorption
- Drug.protein_bound
- 74%–87%
- Drug.metabolism
- Hepatic CYP3A
- Drug.CAS_number
- 137071-32-0
- Drug.ATC_prefix
- D11
- Drug.ATC_suffix
- AH02
via Wikipedia infobox
Chemical data
- Formula
- C43H68ClNO11
- Molecular weight
- 810.4 g/mol
- IUPAC name
- (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(E)-1-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone
- SMILES
- CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C
- InChIKey
- KASDHRXLYQOAKZ-XDSKOBMDSA-N
- XLogP
- 3.8
- Polar surface area
- 158 Ų
- H-bond donors
- 2
- H-bond acceptors
- 11
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2001
- Admin. routes
- topical
- Indications
- atopic eczema, Eczematoid dermatitis, Vitiligo, lichen planus
via ChEMBL · EBI
Research
1,104 papers- Pimecrolimus: a review.Journal of the European Academy of Dermatology and Venereology : JEADV · 2003
- Off-label Uses of Topical Pimecrolimus.Journal of cutaneous medicine and surgery · 2019
- Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial.Pediatrics · 2015
- Pimecrolimus in dermatology.Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia · 2009
- Pimecrolimus 1% cream for mild-to-moderate atopic dermatitis: a systematic review and meta-analysis with a focus on children and sensitive skin areas.European journal of dermatology : EJD · 2023
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 809.448
- Has use
- medication
Show 7 more facts
- chemical formula
- C₄₃H₆₈ClNO₁₁
- World Health Organisation international non-proprietary name
- pimecrolimus
- medical condition treated
- atopic dermatitis
- isomeric SMILES
- CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C
- canonical SMILES
- CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C
- Commons category
- Pimecrolimus
- legal status (medicine)
- boxed warning
Sources (5)
via Wikidata · CC0
~6 min read
Encyclopedic overview
7 sectionsContents
- Medical uses
- Atopic dermatitis
- Side effects
- Pharmacology
- Development and production
- References
- External links
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 464206673 | IUPAC_name = (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-3-{(E)-2-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]-1-methylvinyl}-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosin-1,7,20,21(4H,23H)-tetrone | image = Pimecrolimus.svg | image_class = skin-invert-image | width = 200 | image2 = Pimecrolimus ball-and-stick.png | image_class2 = bg-transparent
| tradename = Elidel | Drugs.com = | pregnancy_AU = B3 | pregnancy_US = C | legal_US = Rx-only | routes_of_administration = topical | class = immunosuppressant
Excerpted from Wikipedia’s “pimecrolimus” article, available under the CC BY-SA 4.0 licence.
Available in 20 languages
- Español
- Français
- Deutsch
- Русский
- Português
- العربية
- azb
- Bahasa Indonesia
- Nederlands
- Odia
- Polski
- Serbian
- Serbian (Latin)
- Slovak
- Swahili
- Telugu
- Tiếng Việt
- Welsh
Show 1 more
via Wikidata sitelinks · CC0